Ibrutinib (I) plus bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a 2-year follow-up of the HELIOS study. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Fraser, Graeme
  • Cramer, Paula
  • Demirkan, Fatih
  • Santucci Silva, Rodrigo
  • Pylypenko, Halyna
  • Grosicki, Sebastian
  • Janssens, Ann
  • Pristupa, Aleksander
  • Mayer, Jiri
  • Dilhuydy, Marie-Sarah
  • Loscertales, Javier
  • Goy, Andre
  • Avigdor, Abraham
  • Rule, Simon
  • Phelps, Charles
  • Mahler, Michelle
  • Salman, Mariya
  • Howes, Angela J
  • Balasubramanian, Sriram
  • Chanan-Khan, Asher Alban Akmal

publication date

  • May 20, 2016